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Protein interactionsThe inﬂuenza polymerase complex composed of PA, PB1 and PB2, plays a key role in viral replication and
pathogenicity. Newly synthesized components must be translocated to the nucleus, where replication and
transcription of viral genomes take place. Previous studies suggest that while PB2 is translocated to the nu-
cleus independently, PA and PB1 subunits could not localize to the nucleus unless in a PA–PB1 complex. To
further determine the molecular interactions between the components, we created a panel of 16 hybridoma
cell lines, which produce monoclonal antibodies (mAbs) against each polymerase component. We showed
that, although PB1 interacts with both PA and PB2 individually, nuclear localization of PB1 is enhanced
only when co-expressed with PA. Interestingly, one of the anti-PA mAbs reacted much more strongly with
PA when co-expressed with PB1. These results suggest that PA–PB1 interactions induce a conformational
change in PA, which could be required for its nuclear translocation.
© 2012 Elsevier Inc. All rights reserved.Introduction
Inﬂuenza A virus has been a major threat to public health for cen-
turies. The emergence of new human infections occurs through reas-
sortment of human and avian viral genes or by direct mutation of
avian or swine viruses. It is becoming increasingly clear that speciﬁc
mutations in avian virus polymerase genes can expand the viral
host range, althoughmolecular mechanisms of host adaptation by po-
lymerase mutation are not known (Bussey et al., 2010, 2011; Naffakh
et al., 2008; Yamada et al., 2010). The inﬂuenza A virus polymerase,
which is responsible for genome replication and transcription, is com-
posed of three components: PA, PB1 and PB2. PB1 contains the cata-
lytic site for RNA synthesis, while PB2 binds the cap structure of
cellular pre-mRNA, which is cleaved by PA and used as a primer for
viral mRNA synthesis (Boivin et al., 2010). Unlike other RNA viruses,
inﬂuenza genome replication and transcription takes place in the nu-
cleus of infected host cells. Therefore, nuclear translocation of the
components and assembly of the polymerase complex in the nucleus
are essential for viral growth. Each polymerase component has a pu-
tative nuclear localization signal (NLS) (Boulo et al., 2007). When
expressed alone, PB2 is efﬁciently translocated to the nucleus, while
PA and PB1 are distributed both in the cytoplasm and in the nucleus.
However, it has been shown that co-expression of PA and PB1 signif-
icantly enhances nuclear accumulation of these proteins (Fodor andgy and Immunology, University
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rights reserved.Smith, 2004). It is proposed that PA and PB1 form dimers in the cyto-
plasm, which are imported into the nucleus where they associate
with PB2 to form the trimeric polymerase complex (Deng et al.,
2005, 2006; Fodor and Smith, 2004; Huet et al., 2010). A recent
study using a bimolecular ﬂuorescence complementation assay, how-
ever, suggested that a direct interaction between PA and PB2 occurs
in the cytoplasm, and that this dimer is subsequently transported
into the nucleus (Hemerka et al., 2009).
Most studies on polymerase protein interactions have been per-
formed using proteins tagged with either eGFP or TAP, which could
inﬂuence the molecular interactions of the proteins (Deng et al.,
2005, 2006; Fodor and Smith, 2004). To further characterize the na-
tive polymerase proteins, we created a panel of 16 mAbs against po-
lymerase components. We then used the mAb panel to analyze the
molecular interactions between the components and also to deter-
mine the localization of the proteins in the host cell. Our results are
consistent with the previous model suggesting that the PA–PB1 inter-
action is required for nuclear localization of the proteins. We also
found an anti-PA mAb that preferentially binds to PA only when it
is in complex with PB1, suggesting a conformational difference be-
tween monomeric PA and PA in a heterodimer with PB1, which
could be required for nuclear translocation of the complex.
Results
Production and characterization of mAbs
Hybridoma cell lines were produced using published protocols
(Fuller et al., 2001) by immunizing Balb/c mice with the puriﬁed
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expressed by recombinant baculoviruses (Aggarwal et al., 2010).
After a series of fusions between splenocytes isolated from immu-
nized mice and Sp2/0 mouse myeloma cells, we obtained a total of
16 hybridoma cell lines which secrete mAbs speciﬁc for the polymer-
ase proteins. Among them, 6 hybridomas produce anti-PA, 4 anti-PB1
and 6 produce anti-PB2 mAbs (Table 1). All mAbs were of the IgG1
subtype, except F1-2F6 which was IgG2b. Polymerase components
recognized by the mAbs were identiﬁed by immunoﬂuorescence
assay (IF), using 293T cells transfected with cDNAs encoding the
Nan polymerase genes. Western blot analysis showed variations in
reactivity of the mAbs with denatured proteins. Anti-PA mAbs F1-
2C3, F1-2F6, F4-296, and F5-32, but not F1-2A5 or F7-236 reacted
with PA protein in Western blot analysis. All of the anti-PB1 mAbs
reacted with the viral antigen; however, none of the anti-PB2 mAbs
were positive by Western blot (Table 1).
We also tested the speciﬁcity of the mAbs with polymerase
proteins from three strains, A/WSN/33 (WSN), A/Aichi/2/68
(Aichi), and A/California/04/09 (Cal), in addition to Nan. Sequence
analysis revealed that the polymerase proteins of these strains are
well conserved. Nan PA protein is 96, 95, and 97% identical to
WSN, Aichi and Cal, respectively. Nan PB1 shares 96, 97, and
95% identity, and Nan PB2 is 93, 93, and 95% identical to WSN,
Aichi and Cal, respectively. However, our mAb panel exhibited
speciﬁcity against the polymerase proteins from these strains
(Table 1). The anti-PA mAb F5-32 reacted equally well with all
of the strains tested, while F1-2F6 did not react with Cal PA. The
anti-PB1 mAb F5-46 recognized Nan, but not the other PB1 pro-
teins tested. All the anti-PB2 mAbs reacted with PB2 from all 4
strains tested (Table 1).
Interactions between polymerase components
Using these mAbs, we next determined the molecular interactions
between untagged polymerase components. Previous structural ana-
lyses of the puriﬁed domains of polymerase proteins have identiﬁed
interacting sites between the components. The C-terminal domain
of PA interacts with the N-terminal region of PB1, and the C-
terminal region of PB1 interacts with the N-terminal domain of PB2
(He et al., 2008; Obayashi et al., 2008; Sugiyama et al., 2009). In addi-
tion, a recent report suggests a direct interaction between PA and
PB2, although this has not been conﬁrmed by another group
(Hemerka et al., 2009).Table 1
Characterization of the monoclonal antibodies against polymerase proteins.
Monoclonal
antibodies
Isotype Bind to Reactivity by Reactivity witha
Western IF IP WSN Aichi Cal Nan
F1-2A5 IgG1 PA – + + + + + +
F1-2C3 IgG1 PA + + + + + + +
F1-2F6b IgG2b PA + + + + + – +
F4-296 IgG1 PA + + + + + + +
F5-32 IgG1 PA + + – + + + +
F7-236 IgG1 PA – + + + + + +
F5-10 IgG1 PB1 + + – + + + +
F5-19 IgG1 PB1 + + + + + + +
F5-46 IgG1 PB1 + + + – – – +
F7-87 IgG1 PB1 + + + + + + +
F5-59 IgG1 PB2 – + + + + + +
F5-116 IgG1 PB2 – + + + + + +
F5-122 IgG1 PB2 – + + + + + +
F5-195 IgG1 PB2 – + + + + + +
F6-36 IgG1 PB2 – + + + + + +
F7-168 IgG1 PB2 – + + + + + +
a Reactivity was determined byWestern blotting for mAbs that react with denatured
proteins. All other mAbs were tested by radioimmunoprecipitation.
b In addition to PA, mAb F1-2F6 binds to multiple cellular proteins in IF and IP, but
not in Western.Most of the previous studies on the interactions between poly-
merase components have been conducted using proteins tagged
with relatively large TAP or GFP tags, which may affect heterotri-
mer complex formation. To analyze the molecular interactions be-
tween the polymerase components, we co-expressed multiple
components of the polymerase complex in various combinations
and performed immunoprecipitation reactions with speciﬁc
mAbs. When PB1 was co-expressed with PA, both PA and PB1
were co-immunoprecipitated in the presence of the anti-PA mAb
F4-296 (Fig. 1A, top panel, lane 4). Similarly, both PB1 and PA
co-immunoprecipitated in the presence of the anti-PB1 mAb F5-
19 (Fig. 1A, middle panel, lane 4). In addition, when PB1 and
PB2 were co-expressed, the anti-PB1 mAb F5-19 or the anti-PB2
mAb F6-36 co-immunoprecipitated PB2 or PB1, respectively
(Fig. 1A, middle and bottom panels, lane 6). These results are con-
sistent with the available structural information indicating PA–
PB1 and PB1–PB2 interactions.
PA and PB2 co-migrate in SDS-PAGE analysis (Fig. 1A, lane 5),
making it necessary to determine direct PA–PB2 interactions using
co-immunoprecipitation followed by Western blot analysis. Either
an anti-PA or anti-PB2 mAb in complex with Protein G-Dynabeads
was reacted with cell lysates expressing PA alone, PB2 alone, PA and
PB2 together, or PA, PB1 and PB2 together. The presence of PA or
PB2 was then determined by Western blotting. The anti-PB2 mAb
F6-36 immunoprecipitated PA only when all three components, PA,
PB1, and PB2, were expressed together (Fig. 1B, lane 4). When only
PA and PB2 were expressed together, the anti-PB2 mAb did not co-
immunoprecipitate PA (lane 3). The same results were obtained
when anti-PA mAb was used for immunoprecipitation (data not
shown). Our experiment failed to detect the PA–PB2 interaction re-
cently reported using the bimolecular ﬂuorescence complementation
assay (Hemerka et al., 2009), which is consistent with reportsFig. 1. Radioimmunprecipitation of polymerase proteins expressed in various combina-
tions. A) [35S]Met/Cys-labeled proteins in total lysates were used for immunoprecipita-
tion with indicated mAbs. B) Co-immunoprecipitation of polymerase proteins. Total
lysates of radiolabeled cells expressing the indicated polymerase components were ap-
plied for immunoprecipitation with anti-PB2 mAb (F6-36). Half of each sample was an-
alyzed by PhosphorImager, and the rest was applied for Western blot analysis using
anti-PA mAb (F1-2F6). The additional band (*) could be Hsp90 associated with PB2
(Deng et al., 2005).
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cells (Ohtsu et al., 2002; Toyoda et al., 1996).
Translocation of polymerase components
We next determined the distribution of the polymerase compo-
nents expressed alone or as a complex in HeLa cells by IF using our
mAbs. As expected from recent studies, PA and PB1, when expressed
individually, localized both in the nucleus and the cytoplasm of HeLa
cells (Fig. 2). In sharp contrast, the majority of PB2, when expressed
alone, localized in nuclei. However, when expressed as a PA–PB1–
PB2 complex, both PA and PB1 were detected mainly in the nucleus,
suggesting that the interactions between the components affect the
distribution of the proteins in cells (Fig. 2). Previous studies showed
that PA–PB1 complex formation is required for the nuclear transloca-
tion of both proteins (Fodor and Smith, 2004). PB1 also interacts with
PB2 (Fig. 1), which translocates to nuclei by itself, but the effect of a
PB1–PB2 interaction on nuclear translocation of PB1 has not been
clearly identiﬁed, except in studies using tagged proteins (Huet et
al., 2010). To determine the effects of co-expressed PA and PB2 on nu-
clear translocation of PB1, we expressed PB1 fused with eGFP at its C-
terminus (PB1eGFP) together with PA or PB2 and visualized the local-
ization of the proteins by ﬂuorescent microscopy (Fig. 3). First, we
conﬁrmed that the fusion of an eGFP tag to PB1 did not inﬂuence
the interaction with PA and PB2 by co-immunoprecipitation assay.
As shown in Fig. 3A, PB1eGFP, when expressed with PA or PB2, was
immunoprecipitated with PA or PB2 mAbs, indicating that neither
PB1–PA nor PB1–PB2 interactions were interrupted by the eGFP tag
at the C-terminus of PB1. We next expressed PB1eGFP together with
PA to determine the localization of PB1eGFP in cells co-expressing
PA using IF analysis. In cells expressing PB1eGFP alone, PB1eGFP lo-
calized mainly in the cytoplasm and, to a lesser extent, in the nucleus
(Fig. 3B arrow). However, in cells co-expressing both proteins, the
majority of PB1eGFP was detected in the nuclei (arrowheads in
Fig. 3B). In sharp contrast, co-expression of PB2 did not signiﬁcantly
affect the localization of PB1eGFP (arrowheads in Fig. 3C), as ob-
served with those transfected with PB1eGFP alone (data not
shown). These results indicate that although PB1 can interact withFig. 2. IF analysis of the localization of polymerase components expressed alone or al-
together in cells. HeLa cells were transfected with cDNAs that express WSN PA, PB1 or
PB2, alone (right columns) or all together (left columns), and localization of the pro-
teins was determined by IF using the speciﬁc mAbs indicated in the ﬁgure.both PA and PB2, PB1 must interact with PA to allow nuclear translo-
cation of PB1.
Enhanced reactivity of an anti-PA mAb to the PA–PB1 complex
The molecular mechanism that allows efﬁcient nuclear transloca-
tion of the PA–PB1 complex, but not PA or PB1 alone, is not clearly un-
derstood. Previous studies, however, have shown that RanBP5 binds
to the PA–PB1 complex, and that this interaction is required for efﬁ-
cient nuclear translocation of the PA–PB1 complex (Deng et al.,
2006). Conversely, a PB1 mutation that abolishes the interaction
with RanBP5 reduced nuclear localization of the complex. However,
the mutation did not completely prevent nuclear translocation, sug-
gesting that other host cell factors that interact with the complex
are involved in nuclear import of the proteins (Hutchinson et al.,
2011). It is possible that the PA–PB1 interaction induces a conforma-
tional change in the complexed proteins, which allows an interaction
with cellular proteins leading to efﬁcient nuclear import. Therefore,
experiments were conducted to investigate whether any of the anti-
PA mAbs show higher afﬁnity to the PA–PB1 complex than to mono-
meric proteins. First, we compared the reactivity of the anti-PA mAbs
to PA or the PA–PB1 complex by enzyme-linked immunosorbent as-
says (ELISA) using puriﬁed proteins expressed by recombinant bacu-
loviruses. PA was puriﬁed using a recombinant baculovirus which
expresses TAP-tagged Nan PA (Aggarwal et al., 2010). The PA–PB1
complex was puriﬁed from insect cells co-infected with recombinant
baculoviruses expressing TAP-tagged PB1 and tag-free PA by TAP pu-
riﬁcation techniques, which allowed preparation of PA–PB1 complex
free of PA monomer. ELISA plates were coated with puriﬁed proteins
containing the same amount of PA and reactivity of the anti-PA mAbs
was tested. The mAb F5-32 reacted equally well with both PA alone
and with the PA–PB1 complex (Fig. 4). F1-2F6 also reacted well
with both antigens, although it reacted with PA alone slightly better
than with the complex. The mAbs F1-2A5 and F4-296 reacted more
strongly with the PA–PB1 complex than with PA alone. F7-236
reacted with the PA–PB1 complex, but not with PA expressed alone.
However, this loss of reactivity could be due to the location of the
TAP tag on the C-terminal of PA, as described below. F1-2C3, in con-
trast, reacted more strongly with PA alone than with the PA–PB1
complex. Anti-PB1 mAb recognized the PA–PB1 complex, but not PA
alone, while anti-PB2 mAb F6-36 reacted with neither antigen, as
expected.
Because some of the mAbs reacted more strongly to the PA–PB1
complex than to the PA monomer, we further determined the reactiv-
ity of the mAbs by radioimmunoprecipitation (RIP) using untagged
polymerase proteins expressed in 293T cells. We expressed PA
alone, or PA and PB1 together in 293T cells, and the same amounts
of radiolabeled lysates were used for immunoprecipitation. As found
with the ELISA results, the mAb F1-2A5 immunoprecipitated greater
amounts of PA in complex with PB1 than PA expressed alone
(Fig. 5). The mAb F1-2C3 immunoprecipitated PA expressed alone,
but not the PA–PB1 complex, although the reactivity was very weak.
In contrast with the ELISA results, F4-296 immunoprecipitated both
PA and the PA–PB1 complex. The mAb F1-2F6, which reacted well
to both PA and PA–PB1 in ELISA, immunoprecipitated not only PA,
but also many other cellular proteins nonspeciﬁcally (data not
shown). F5-32 failed to immunoprecipitate PA either expressed
alone or in complex with PB1. F7-236 immunoprecipitated both the
PA–PB1 complex and the PA monomer, although reactivity with the
PA monomer was weaker than with the PA–PB1 complex. In ELISA
using C-terminal-tagged proteins, F7-236 did not react with tagged
PA (Fig. 4), suggesting that F7-236 reacts with an epitope that is
masked by the peptide tag at the C-terminus.
The reactivity of the PA mAbs was also tested by IF assay (Fig. 6).
In agreement with the ELISA and RIP results, F1-2A5 reacted with
PA in complex with PB1 much more strongly than with PA alone.
Fig. 3.Nuclear translocation of PB1eGFP by PA, but not PB2. A) Cells transfected with expression vectors that contain PB1eGFP, PA, or PB2 were labeled with [35S]Met/Cys and lysates
were used for immunoprecipitation using the indicated mAbs. B) and C) HeLa cells transfected with PB1eGFP together with PA (B) or PB2 (C) were processed for IF analysis using
anti-PA or anti-PB2 mAbs. Arrowheads indicate cells expressing both PB1eGFP with PA or PB2, and an arrow in (B) indicates a cell expressing PB1eGFP alone. The additional faint
bands present (*) could be cleaved PB1eGFP fragments.
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complex, although ﬂuorescent signals were stronger in cells expres-
sing both PA and PB1. F1-2C3 reacted strongly with PA alone and
weakly with the PA–PB1 complex, while F5-32 reacted equally well
with PA alone and with the PA–PB1 complex (Fig. 6A). In cells
infected with WSN virus, F4-296, F5-32 and F7-236 detected PA in
both the nucleus and cytoplasm at 9 h post infection (Fig. 6B). F1-
2A5 and F1-2C3, however, did not react well with PA in virus-
infected cells, suggesting the interaction with PB2 or NP may block
the PA epitope recognized by these mAbs.
We also conﬁrmed the reactivity of the mAbs using 2009 pandemic
H1N1 (Cal) PA. 293T cells expressing Flag-tagged Cal PA alone or togeth-
er with untagged Cal PB1 were processed for IF. As expected, F1-2A5
reacted with PA only when co-expressed with PB1 (Fig. 7). In addition,
PA proteins recognized by F1-2A5were detected only in nuclei. Similarly,
signals of F4-296 and F7-236 were detected mainly in the nuclei of cells
expressing both PA and PB1. Interestingly, signal from F1-2C3was found
mainly in the cytoplasm of cells expressing both PA and PB1, suggesting
that PA not in complex with PB1 remains in the cytoplasm.
To further examine the location of the epitopes recognized by the
mAbs, Cal PA fragments containing either residues 1–257 or 258–716
were expressed individually and reactivity with the mAbs were de-
termined by IF. F1-2C3, F4-296, and F7-236 reacted with an epitope
in residues 258–716, and F5-32 reacted with the N-terminal domain,
containing residues 1–257. F1-2A5 did not react with either domain.
Our data derived from the three different methods indicate the pres-
ence of an epitope on PA, recognized by F1-2A5, which becomesavailable only when PA and PB1 form a complex. These results sug-
gest a conformational change in PA induced by binding to PB1 or
the presence of an epitope composed of both PA and PB1.
Discussion
Recent studies have highlighted the importance of polymerase
proteins in host adaptation of inﬂuenza A viruses. Speciﬁc muta-
tions in PB2 and PA allow the avian inﬂuenza virus polymerase
to be strongly active in mammalian cells, where otherwise an
avian polymerase would be inactive (Bussey et al., 2010, 2011;
Gabriel et al., 2005; Hatta et al., 2001; Li et al., 2005; Yamada et
al., 2010; Yao et al., 2001). The mechanism of how speciﬁc muta-
tions in polymerase proteins confer functionality in mammalian
hosts is not known. However, previous work suggests that a mu-
tation at PB2 residue 627 affects the interaction between the po-
lymerase complex and NP, which is essential for viral genome
replication and transcription (Labadie et al., 2007; Mehle and
Doudna, 2008; Rameix-Welti et al., 2009). Other studies suggest
that speciﬁc PB2 mutations enhance binding to importin-α and
affect nuclear translocation (Boivin and Hart, 2011; Gabriel et al.,
2008). In addition, the contribution of mammalian-speciﬁc inter-
acting proteins is suggested indicating that either an inhibitory
factor blocks the avian polymerase or a co-factor enhances the
human polymerase (Mehle and Doudna, 2008; Moncorge et al.,
2010). So far, however, any conclusive mechanism that explains
host adaptation by polymerase mutations has not been proposed.
Fig. 4. Reactivity of mAbs against puriﬁed PA or PA–PB1 complex determined by ELISA. Puriﬁed PA or PA–PB1 complex containing an equivalent amount of PA was coated on ELISA
plates and reacted with the indicated mAbs at various dilutions. Solid line: PA monomer, dashed line: PA–PB1 complex.
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study, will contribute to the understanding of the role of the in-
ﬂuenza polymerase in host adaptation and pathogenicity.Fig. 5. Immunoprecipitation of PA or the PA–PB1 complex by the indicated anti-PA
mAbs. 293T cells expressing the indicated polymerase components were radiolabeled
and the same amounts of total lysates were applied for immunoprecipitation using
the ﬁve different anti-PA mAbs.To facilitate further analysis of the functions and molecular in-
teractions of polymerase proteins, we created 16 hybridoma cell
lines which secrete mAbs against polymerase components. This
panel of mAbs allows direct analysis of the molecular interactions
between native viral components without the addition of a tag.
Recent analyses of polymerase proteins have revealed the struc-
ture of a direct interaction site between the C-terminal region of
PA with the N-terminal peptide of PB1 (He et al., 2008;
Obayashi et al., 2008). Also, the C-terminal region of PB1 and
the N-terminal region of the PB2 peptide were shown to form a
complex by X-ray analysis (Sugiyama et al., 2009). Consistent
with structural data, PB1 was co-immunoprecipitated with PA or
PB2 (Fig. 1A), which agrees with previous reports (Deng et al.,
2005; Gonzalez et al., 1996; Perez and Donis, 2001; Toyoda et
Fig. 6. IF analysis of anti-PA mAb reactivity in transfected or infected cells. A) 293T cells were transfected with pCAGGS-WSNPA alone or together with pCAGGS-WSNPB1. PA in the
cells was stained with various anti-PA mAbs and anti-mouse Texas Red followed by counterstaining with DAPI. The same exposure time was used for each mAb for detection of PA
or PA–PB1. B) HeLa cells were infected with WSN for 9 h and reacted with various anti-PA mAbs, as described above.
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and PB2 without PB1 using a bimolecular ﬂuorescence comple-
mentation assay (Hemerka et al., 2009). However, a majority of
reports suggest no direct interaction between PA and PB2. Our
studies also did not detect the formation of a PA–PB2 complex
in the absence of PB1 (Fig. 1B), suggesting that PA–PB2 direct
binding, if it does exist, would be a low afﬁnity interaction.
Unlike in the majority of RNA viruses, inﬂuenza genome replica-
tion and transcription take place in the nucleus, requiring nuclear
translocation of the polymerase components for virus replication
(Boulo et al., 2007). Early studies suggest that individually expressed
PA, PB1, and PB2 can enter the nuclei (Akkina et al., 1987; Jones et al.,
1986; Mukaigawa and Nayak, 1991; Nath and Nayak, 1990; Nieto et
al., 1992, 1994), and nuclear localization signals (NLS) in each poly-
merase component have been identiﬁed (Mukaigawa and Nayak,
1991; Nath and Nayak, 1990; Nieto et al., 1994). Unlike earlier stud-
ies, but in agreement with the study by Fodor and Smith (2004), indi-
vidually expressed PA and PB1 were found to be distributed mainly in
the cytoplasm but also to some extent in the nucleus, while PB2 accu-
mulated only in the nucleus (Fig. 2). Co-expression of the three com-
ponents was shown to result in the accumulation of all three
components in the nucleus, supporting the hypothesis that interac-
tion between the components enhances nuclear translocation of PA
and PB1. Using GFP-tagged PB1, we conﬁrmed the previous ﬁnding
that co-expression of PA, but not PB2, signiﬁcantly enhances nuclear
localization of PB1 (Fodor and Smith, 2004). It is still unclear why in-
teraction with PB2, which can be detected in transfected cells (Fig. 1),
does not allow the nuclear translocation of PB1 (Fig. 3). Since co-
expression of PB1eGFP did not affect the nuclear accumulation of
PB2, it is possible that the PB1–PB2 interaction we detected by co-
immunoprecipitation could only occur in the nucleus between PB2
and the fraction of PB1 located in the nucleus.
The binding of PB1 to PA dramatically changed the localization of
both PB1 and PA proteins (Fig. 3), which was not the case with the in-
teraction of PB1 with PB2, supporting the hypothesis that PA–PB1
complex formation precedes nuclear translocation (Deng et al.,
2006; Fodor and Smith, 2004). A recent study showed that interaction
of the PA–PB1 dimer with the nuclear import factor RanBP5 plays a
major role in the nuclear translocation of the complex (Deng et al.,2006; Hutchinson et al., 2011). Mutation at the PB1 NLS abolished
the interaction with RanBP5 and reduced, but did not prevent, nucle-
ar localization of the complex. Their data suggest that interaction
with RanBP5 plays an important role in the nuclear translocation of
the PA–PB1 complex. However, this also indicates that other factors
are involved in the nuclear translocation of the PA–PB1 complex,
since a PB1 mutation that abolished the interaction with RanBP5 did
not completely prevent nuclear translocation of the PA–PB1 complex.
It is possible that the NLS of PA is involved in the nuclear translocation
of the complex. Because PA was not able to translocate to nuclei efﬁ-
ciently when expressed alone (Fig. 2), the proposed PA NLS, which
exists within the N-terminal 247 residues of PA (Nieto et al., 1994),
could be exposed by a structural change upon binding to PB1. In
fact, mAb F1-2A5 reacted with the PA–PB1 complex much stronger
than with PA alone, which may reﬂect the structural difference in
PA (Figs. 4–7). As far as we are aware, this is the ﬁrst mAb that
was found to recognize the PA–PB1 complex better than the PA
monomer. It is also possible, however, that F1-2A5 recognizes an epi-
tope composed of both PA and PB1. The PA molecule is composed of
two domains separated by a long linker peptide that can be cleaved
by limited tryptic digestion (Guu et al., 2008; Hara et al., 2006). PA
in complex with PB1 was reported to be highly resistant to tryptic di-
gestion as compared to monomeric PA, also suggesting a possible
conformational change in PA upon PB1 binding (Guu et al., 2008). To-
gether with the previous studies, our data suggest that PA binding to
PB1 induces a structural change, which may enhance an interaction
with cellular proteins resulting in nuclear translocation of the PA–
PB1 complex. Further study on the role of the NLS in PA is expected
to unveil the mechanism of nuclear translocation of the PA–PB1
complex.
Materials and methods
Preparation of polymerase complex
Polymerase complex was prepared as described previously
(Aggarwal et al., 2010). Brieﬂy, PA, PB1, and PB2 genes of A/chicken/
Nanchang/3-120/01 (H3N2) were cloned into pVL1392 (Invitrogen)
and recombinant baculoviruses were produced by the protocols
Fig. 7. IF analysis of mAb reactivity and cellular localization of antigens. 293T cells were transfected with pCAGGS expressing the indicated genes and reacted with anti-PA mAbs or
anti-Flag Ab. PA, PA1–257 and PA258–716 were tagged with Flag. Cells were counterstained with DAPI. N: nuclear localization, C: cytoplasmic localization, N+C: both nuclear and
cytoplasmic localization, –: no reactivity.
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was tagged at the C-terminus with the tandem afﬁnity puriﬁcation
(TAP) tag, which consisted of a thrombin cleavage site followed by a
6X His tag, a tobacco etch virus (TEV) cleavage site and ﬁnally an
IgG-binding domain. Trimeric polymerase complex was prepared
from Tni insect cells infected with the three recombinant viruses by
the TAP puriﬁcation technique.
Immunization of mice and preparation of hybridoma cell lines
Balb/c mice were injected subcutaneously with 20 μg of the puri-
ﬁed polymerase complex mixed with Freund's Incomplete Adjuvant.
Two booster immunizations (20 μg of protein) were given intraperi-
toneally at day 10 and 18. Splenocytes were isolated on day 21. Hy-
bridoma cells were generated by standard procedures using Sp2/
0 myeloma cells (Fuller et al., 2001). The hybridoma culture superna-
tants were screened by ELISA using puriﬁed polymerase proteins as
antigen. The isotyping of obtained mouse mAbs was performed
using IsoStrip™ Mouse Antibody Isotyping Kit (Santa Cruz Biotech-
nology). Cell lines secreting the mAb of interest were cloned using
limiting dilutions. The mAbs were produced from the hybridoma
cells as ascites ﬂuid, culture supernatant, or concentrated culture
supernatant using the CELLine bioreactor system (Sigma). All of the
hybridoma cells were deposited to BEI resources.cDNAs
WSN PA, PB1, and PB2 genes in pCAGGSwere generously provided
by Y. Kawaoka (University of Wisconsin, Madison). WSN PB1 fused
with the eGFP gene was created as follows. First, a KpnI site was cre-
ated at the end of the PB1 coding region using the QuickChange Mu-
tagenesis Kit (Stratagene). The eGFP gene was ampliﬁed by PCR from
pEGFP-N1 (Clontech) using primers containing KpnI sites ﬂanking the
gene, and was inserted into the PB1 gene in pCAGGS. Cal PA and PB1
genes were synthesized by RT-PCR from RNA extracted from cells
infected with A/California/04/2009 (H1N1). The PB1 gene was direct-
ly cloned into pCAGGS. PA gene was ﬁrst subcloned into pCMV-Tag4a
(Stratagene) to obtain a Flag-tagged gene before insertion into the
pCAGGS vector. Flag-tagged CalPA1–257 was constructed from
pCAGGS-CalPA by PCR using a forward primer containing a SacI site
and reverse primer containing the Flag tag sequence and a SphI site.
Similarly, CalPA258–716 was constructed using appropriate primers
that amplify the PA gene encoding residues 258–716 with SacI and
SphI sites in forward and reverse primers, respectively.
Immunological assays
To identify the polymerase component recognized by each mAb,
293T cells were transfected with pCAGGS vectors containing Nan
58 L.A. MacDonald et al. / Virology 426 (2012) 51–59PA, PB1, or PB2 by Lipofectamine 2000 (Invitrogen). Twenty-four h
after transfection, cells were ﬁxed and permeabilized with metha-
nol/acetone (1:1), and reacted with the culture supernatants of the
hybridomas, followed by detection with anti-mouse IgG-Texas Red
(TR). For Western blot analysis, 40 μg of puriﬁed virus (Nan) grown
in eggs were used as antigen. After separation by SDS-PAGE, viral pro-
teins were transferred to a PVDF membrane, and reacted with each
mAb.Immunoprecipitation
To compare the reactivity of mAbs with PA alone or with the PA–
PB1 complex, 293T cells were transfected with either pCAGGS-
WSNPA and pCAGGS, or pCAGGS-WSNPA and pCAGGS-WSNPB1 by
Lipofectamine 2000. After 16 h incubation, cells were labeled with
[35S]Met/Cys (Perkin Elmer) for 6 h, and lysed with a Nuclear Extrac-
tion Triton buffer (20 mMHepes pH7.9, 1.5 mMMgCls, 500 mM NaCl,
0.2 mM EDTA, 20% Glycerol, 1% Triton X-100). Labeled proteins in ly-
sates were immunoprecipitated using speciﬁc mAbs and Dynabeads
Protein G (Invitrogen).Enzyme-linked immunosorbent assay (ELISA)
PAtap and the PA–PB1tap complex were puriﬁed from Tni insect
cells infectedwith recombinant baculoviruses, as described above. Puri-
ﬁed proteins were analyzed by SDS-PAGE, stained with SimplyBlue
SafeStain (Invitrogen), and aliquots containing the same amount of PA
protein were coated to 96-well plates. The plates were incubated with
dilutions of each mAb, followed by anti-mouse IgG-horseradish peroxi-
dase (1:5000 dilution)(PIERCE) and 2,2′-Azino-bis(3-ethylbenzothia-
zoline-6-sulfonic acid)(Sigma). The optical density of the samples at
405 nm was measured using SpectraMax Plus (Molecular Devices).
The original mAbs were diluted as follows: F1-2A5 (ascites, 1:100),
F1-2C3 (ascites, 1:1000), F1-2F6 (ascites, 1:3000), F4-296 (concentrat-
ed supernatant, 1:300), F5-32 (concentrated supernatant, 1:100), F7-
236 (culture supernatant, 1:30), F7-87 (culture supernatant, 1:10),
and F6-36 (culture supernatant, 1:30).Immunoﬂuorescence analysis
Reactivity of the mAbs and localization of the antigen in cells
transfected with PA or PA–PB1 or infected with WSN were analyzed
by IF. 293T or HeLa cells were transfected with the polymerase
genes in pCAGGS using Lipofectamine 2000 (Invitrogen) or infected
with WSN at a MOI of 0.3. After 24 h transfection or 9 h infection,
cells were ﬁxed with 3.5% formaldehyde in PBS and permeabilized
with methanol/acetone (1:1) at −20 °C. These cells were incubated
with each mAb or anti-Flag rabbit serum (Sigma) followed by anti-
mouse or anti-rabbit IgG-Texas Red (Invitrogen) and counterstained
with DAPI. Dilutions of the mAbs used for the reaction were F1-2A5
(ascites 1:1000), F1-2C3 (ascites 1:1000), F4-296 (concentrated su-
pernatant, 1:1000), F5-32 (concentrated supernatant, 1:1000), F6-
36 (concentrated supernatant, 1:100), F7-87 (culture supernatant,
1:10), F7-168 (culture supernatant, 1:30), and F7-236 (culture super-
natant, 1:30). All the images were taken using an Olympus inverted
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